Company Performance - Marvell Technology (MRVL) closed at $73.73, down 2.4% from the previous trading session, underperforming the S&P 500 which lost 0.51% [1] - Prior to the recent trading, MRVL shares had decreased by 14.38%, contrasting with the Computer and Technology sector's loss of 0.27% and the S&P 500's gain of 0.93% [1] Upcoming Earnings - The company is expected to report an EPS of $0.79, reflecting a 31.67% increase from the same quarter last year [2] - Quarterly revenue is anticipated to be $2.21 billion, which is a 21.4% increase compared to the year-ago period [2] Full Year Estimates - For the full year, analysts project earnings of $2.84 per share and revenue of $8.18 billion, indicating a change of +80.89% in earnings and no change in revenue from the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for Marvell Technology are crucial as they reflect the evolving business dynamics [4] - Positive revisions in estimates signal analysts' confidence in the company's performance and profit potential [4] Zacks Rank and Valuation - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Marvell Technology at 3 (Hold) [6] - Over the last 30 days, the Zacks Consensus EPS estimate has decreased by 0.46% [6] - Marvell Technology has a Forward P/E ratio of 21.16, which is lower than the industry's Forward P/E of 36.01, and a PEG ratio of 0.45 compared to the industry average of 1.99 [7] Industry Context - The Electronics - Semiconductors industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 64, placing it in the top 27% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Oracle's stock closed at $146.67, reflecting a decline of 5.17% from the previous day, underperforming the S&P 500 which fell by 0.51% [1] - Over the past month, Oracle's shares have decreased by 20.17%, significantly underperforming the Computer and Technology sector's loss of 0.27% and the S&P 500's gain of 0.93% [1] Upcoming Earnings - Oracle is expected to report an EPS of $1.7, representing a 15.65% increase compared to the same quarter last year, with a projected quarterly revenue of $16.89 billion, up 19.54% year-over-year [2] Full Year Projections - For the full year, earnings are projected at $7.46 per share and revenue at $66.94 billion, indicating increases of 23.71% and 16.62% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates for Oracle indicate a positive outlook, with a 0.62% increase in the Zacks Consensus EPS estimate over the last 30 days [5] - Oracle currently holds a Zacks Rank of 3 (Hold), reflecting a neutral sentiment among analysts [5] Valuation Metrics - Oracle's Forward P/E ratio stands at 20.73, which is higher than the industry's Forward P/E of 18.28, suggesting a premium valuation [6] - The company's PEG ratio is 1.09, compared to the Computer - Software industry's average PEG ratio of 1.47, indicating a relatively favorable growth outlook [6] Industry Context - The Computer - Software industry is part of the broader Computer and Technology sector, currently holding a Zacks Industry Rank of 90, placing it in the top 37% of over 250 industries [7] - Historically, the top 50% rated industries outperform the bottom half by a factor of 2 to 1, indicating a strong competitive position for Oracle within its industry [7]

Company Overview - Astrazeneca's recent trading session ended at $184.32, reflecting a -2.17% change from the previous day's closing price, which is lower than the S&P 500's daily loss of 0.84% [1] - Over the past month, Astrazeneca's shares have gained 0%, underperforming the Medical sector's gain of 0.16% and the S&P 500's gain of 1.8% [1] Earnings Expectations - The upcoming earnings release on February 10, 2026, is anticipated to show earnings of $2.18 per share, indicating a year-over-year growth of 107.62% [2] - The consensus estimate for revenue is projected at $15.71 billion, representing a 5.48% increase compared to the same quarter of the previous year [2] Full-Year Estimates - The Zacks Consensus Estimates for the full year predict earnings of $9.17 per share and revenue of $58.61 billion, which would reflect year-over-year changes of +123.11% for earnings and 0% for revenue [3] - Recent changes to analyst estimates for Astrazeneca are important as they reflect short-term business trends, with positive revisions indicating analyst optimism [3] Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a strong track record, with 1 rated stocks delivering an average annual return of +25% since 1988 [5] - Currently, Astrazeneca holds a Zacks Rank of 3 (Hold), with the consensus EPS estimate moving 0.44% lower over the last 30 days [5] Industry Context - Astrazeneca operates within the Medical - Biomedical and Genetics industry, which has a Zacks Industry Rank of 94, placing it in the top 39% of over 250 industries [6] - The Zacks Industry Rank measures the strength of individual industry groups, indicating that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [6]

Company Performance - Alibaba's stock closed at $163.65, reflecting a -2.81% change from the previous day's closing price, underperforming compared to the S&P 500's loss of 0.84% [1] - The stock has increased by 7.76% over the past month, outperforming the Retail-Wholesale sector's gain of 6.19% and the S&P 500's gain of 1.8% [1] Earnings Expectations - Analysts anticipate Alibaba will report an EPS of $1.91, indicating a 34.81% decline compared to the same quarter last year, with a projected revenue of $41.26 billion, reflecting a 7.49% increase year-over-year [2] - Full-year estimates predict earnings of $5.98 per share and revenue of $147.21 billion, representing year-over-year changes of -33.63% and +6.57%, respectively [3] Analyst Sentiment - Recent consensus EPS projections have decreased by 6.93% over the past 30 days, and Alibaba currently holds a Zacks Rank of 5 (Strong Sell) [5] - Positive estimate revisions are indicative of analyst optimism regarding the company's business and profitability [3][4] Valuation Metrics - Alibaba's Forward P/E ratio stands at 28.18, which is a premium compared to the industry average Forward P/E of 16.34 [5] - The company has a PEG ratio of 3.26, significantly higher than the industry average PEG ratio of 1.07 [6] Industry Context - The Internet - Commerce industry, part of the Retail-Wholesale sector, has a Zacks Industry Rank of 179, placing it in the bottom 27% of over 250 industries [6] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Palo Alto Networks (PANW) has experienced a decline in stock price and is underperforming compared to the broader market and its sector, with upcoming earnings expected to show growth in EPS and revenue [1][2]. Financial Performance - The upcoming earnings report is anticipated to show an EPS of $0.93, reflecting a 14.81% increase year-over-year, and revenue is expected to reach $2.58 billion, indicating a 14.33% rise compared to the same quarter last year [2]. - For the entire fiscal year, earnings are projected at $3.84 per share and revenue at $10.52 billion, representing increases of 14.97% and 14.12% respectively from the previous year [3]. Analyst Estimates - Recent modifications to analyst estimates indicate a dynamic business environment, with positive revisions suggesting optimism about profitability [4]. - The Zacks Consensus EPS estimate has decreased by 0.32% over the past month, and Palo Alto Networks currently holds a Zacks Rank of 4 (Sell) [6]. Valuation Metrics - Palo Alto Networks has a Forward P/E ratio of 45.65, which is lower than the industry average of 47.58, and a PEG ratio of 2.26 compared to the industry average of 2.49 [7]. Industry Context - The Security industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 207, placing it in the bottom 16% of over 250 industries, indicating weaker performance compared to higher-ranked industries [8].

In the latest close session, Intrusion Inc. (INTZ) was down 3.86% at $1.00. The stock trailed the S&P 500, which registered a daily loss of 0.84%. On the other hand, the Dow registered a loss of 0.34%, and the technology-centric Nasdaq decreased by 1.43%. The company's shares have seen a decrease of 17.46% over the last month, not keeping up with the Computer and Technology sector's gain of 1.75% and the S&P 500's gain of 1.8%.The investment community will be paying close attention to the earnings performan ...

Core Viewpoint - The article highlights Innovex International, Inc. (INVX) as a potentially undervalued stock, supported by various financial metrics indicating strong value characteristics [4][5][6][7]. Group 1: Company Overview - Innovex International, Inc. (INVX) currently holds a Zacks Rank of 2 (Buy) and an A for Value, indicating strong investment potential [4]. - The stock is trading at a P/E ratio of 12.61, significantly lower than the industry average of 16.81, suggesting it may be undervalued [4]. - INVX's Forward P/E has fluctuated between 11.45 and 21.70 over the past year, with a median of 17.76, further indicating its current valuation may be attractive [4]. Group 2: Financial Metrics - The P/B ratio for INVX is 1.2, which is favorable compared to the industry average of 1.40, indicating a potentially strong value proposition [5]. - Over the past 52 weeks, INVX's P/B has ranged from 0.60 to 1.34, with a median of 1.12, reinforcing the notion of its undervaluation [5]. - INVX has a P/CF ratio of 5.88, which is significantly lower than the industry average of 10.30, suggesting strong cash flow relative to its market value [6]. - The P/CF for INVX has varied between 2.67 and 7.21 in the past year, with a median of 5.57, indicating a solid cash outlook [6]. Group 3: Investment Outlook - The combination of the aforementioned metrics positions Innovex International, Inc. as one of the strongest value stocks in the market, particularly when considering its earnings outlook [7].

Company Performance - Humacyte, Inc. closed at $1.02, with a daily increase of +2.24%, outperforming the S&P 500's gain of 0.54% [1] - Over the past month, Humacyte's shares have risen by 2.33%, while the Medical sector has declined by 1.89% [1] Earnings Forecast - The upcoming earnings report is expected to show an EPS of -$0.13, reflecting an 18.75% improvement from the same quarter last year [2] - For the annual period, the Zacks Consensus Estimates predict an EPS of -$0.25 and revenue of $3.15 million, indicating a 76.19% increase in EPS and no change in revenue compared to the previous year [2] Analyst Estimates - Recent changes in analyst estimates for Humacyte are being closely monitored, as they often indicate shifts in short-term business dynamics [3] - Positive revisions in estimates suggest analysts' confidence in the company's performance and profit potential [3] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown that 1 stocks have delivered an average annual return of +25% since 1988 [5] - Humacyte currently holds a Zacks Rank of 3 (Hold), with no changes in the consensus EPS projection over the past 30 days [5] Industry Overview - Humacyte operates within the Medical - Biomedical and Genetics industry, which has a Zacks Industry Rank of 94, placing it in the top 39% of over 250 industries [6] - The Zacks Industry Rank evaluates the strength of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [6]

Group 1 - AST SpaceMobile, Inc. (ASTS) stock decreased by 5.99% to $104.55, underperforming the S&P 500 which gained 0.54% [1] - Over the past month, ASTS shares increased by 33.23%, while the Computer and Technology sector gained 0.44% and the S&P 500 gained 0.74% [1] Group 2 - The upcoming earnings release is projected to show a loss of -$0.18 per share, a 50% decline year-over-year, with expected revenue of $38.27 million, up 1893.02% from the prior-year quarter [2] - For the full year, earnings are projected at -$1.07 per share and revenue at $54.87 million, reflecting changes of -62.12% and 0% respectively from the prior year [3] Group 3 - Recent changes to analyst estimates for AST SpaceMobile, Inc. indicate a shifting business landscape, with positive revisions suggesting analyst confidence in performance [4] - The Zacks Rank system, which evaluates estimated changes, currently ranks AST SpaceMobile, Inc. as 5 (Strong Sell), with a 21.04% decrease in the consensus EPS estimate over the last 30 days [6] Group 4 - The Wireless Equipment industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 73, placing it in the top 30% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Western Union closed at $9.52, with a gain of +1.6% from the previous trading session, outperforming the S&P 500's gain of 0.54% [1] - Over the past month, shares of Western Union gained 1.52%, while the Business Services sector lost 6.48% and the S&P 500 gained 0.74% [1] Upcoming Earnings Report - Western Union is scheduled to release its earnings on February 20, 2026, with projected earnings of $0.43 per share, indicating a year-over-year growth of 7.5% [2] - The Zacks Consensus Estimate for revenue is projected at $1.04 billion, down 2.11% from the previous year [2] Full Year Projections - For the full year, the Zacks Consensus Estimates project earnings of $1.73 per share and revenue of $4.08 billion, reflecting changes of -0.57% and 0% from the prior year, respectively [3] Analyst Estimates and Rankings - Recent revisions to analyst estimates for Western Union are important as they reflect near-term business trends, with positive revisions indicating analysts' confidence in performance [3] - Western Union currently holds a Zacks Rank of 3 (Hold), with a 0.73% rise in the Zacks Consensus EPS estimate over the past month [5] Valuation Metrics - Western Union is trading at a Forward P/E ratio of 5.21, which is a discount compared to the industry average Forward P/E of 11.1 [6] - The company has a PEG ratio of 3, while the Financial Transaction Services industry has an average PEG ratio of 0.94 [6] Industry Context - The Financial Transaction Services industry, part of the Business Services sector, has a Zacks Industry Rank of 183, placing it within the bottom 26% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]